Docking and hydropathic scoring of polysubstituted pyrrole compounds with antitubulin activity

被引:42
作者
Tripathi, Ashutosh [1 ,2 ]
Fornabaio, Micaela [1 ,2 ]
Kellogg, Glen E. [1 ,2 ]
Gupton, John T. [6 ]
Gewirtz, David A. [3 ,4 ]
Yeudall, W. Andrew [5 ]
Vega, Nina E. [7 ]
Mooberry, Susan L. [7 ]
机构
[1] Virginia Commonwealth Univ, Dept Med Chem, Richmond, VA 23298 USA
[2] Virginia Commonwealth Univ, Inst Struct Biol & Drug Discovery, Richmond, VA 23298 USA
[3] Virginia Commonwealth Univ, Dept Pharmacol & Toxicol, Richmond, VA 23298 USA
[4] Virginia Commonwealth Univ, Med Coll Virginia, Massey Canc Ctr, Richmond, VA 23298 USA
[5] Virginia Commonwealth Univ, Sch Dent, Philips Inst Oral & Craniofacial Mol Biol, Richmond, VA 23298 USA
[6] Univ Richmond, Gotwald Ctr Sci, Dept Chem, Richmond, VA 23173 USA
[7] SW Fdn Biomed Res, Dept Physiol & Med, San Antonio, TX 78227 USA
关键词
antitubulin; cytotoxicity; HINT; molecular docking; pyrroles;
D O I
10.1016/j.bmc.2007.11.076
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Compounds that bind at the colchicine site of tubulin have drawn considerable attention with studies indicating that these agents suppress microtubule dynamics and inhibit tubulin polymerization. Data for 18 polysubstituted pyrrole compounds are reported, including antiproliferative activity against human MDA-MB-435 cells and calculated free energies of binding following docking the compounds into models of alpha beta-tubulin. These docking calculations coupled with HINT interaction analyses are able to represent the complex structures and the binding modes of inhibitors such that calculated and measured free energies of binding correlate with an r(2) of 0.76. Structural analysis of the binding pocket identifies important intermolecular contacts that mediate binding. As seen experimentally, the complex with JG-03-14 (3,5-dibromo-4-(3,4-dimethoxyphenyl)-1H-pyrrole-2-carboxylic acid ethyl ester) is the most stable. These results illuminate the binding process and should be valuable in the design of new pyrrole-based colchicine site inhibitors as these compounds have very accessible syntheses. (C) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2235 / 2242
页数:8
相关论文
共 34 条
  • [1] Anticancer drugs from nature - natural products as a unique source of new microtubule-stabilizing agents
    Altmann, Karl-Heinz
    Gertsch, Juerg
    [J]. NATURAL PRODUCT REPORTS, 2007, 24 (02) : 327 - 357
  • [2] Autophagic cell death, polyploidy and senescence induced in breast tumor cells by the substituted pyrrole JG-03-14, a novel microtubule poison
    Arthur, Christopher R.
    Gupton, John T.
    Kellogg, Glen E.
    Yeudall, W. Andrew
    Cabote, Myles C.
    Newsham, Irene F.
    Gewirtz, David A.
    [J]. BIOCHEMICAL PHARMACOLOGY, 2007, 74 (07) : 981 - 991
  • [3] Mapping the binding site of colchicinoids on β-tubulin -: 2-chloroacetyl-2-demethylthiocolchicine covalently reacts predominantly with cysteine 239 and secondarily with cysteine 354
    Bai, RL
    Covell, DG
    Pei, XF
    Ewell, JB
    Nguyen, NY
    Brossi, A
    Hamel, E
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (51) : 40443 - 40452
  • [4] Protein-based virtual screening of chemical databases. 1. Evaluation of different docking/scoring combinations
    Bissantz, C
    Folkers, G
    Rognan, D
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (25) : 4759 - 4767
  • [5] Comparative molecular field analysis of colchicine inhibition and tubulin polymerization for combretastatins binding to the colchicine binding site on β-tubulin
    Brown, ML
    Rieger, JM
    Macdonald, TL
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2000, 8 (06) : 1433 - 1441
  • [6] 2-amino and 2′-aminocombretastatin derivatives as potent antimitotic agents
    Chang, Jang-Yang
    Yang, Ming-Fang
    Chang, Chi-Yen
    Chen, Chi-Ming
    Kuo, Ching-Chuan
    Liou, Jing-Ping
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (21) : 6412 - 6415
  • [7] Laulimalide and synthetic laulimalide analogues are synergistic with paclitaxel and 2-methoxyestradiol
    Clark, Erin A.
    Hills, Patrice M.
    Davidson, Bradley S.
    Wender, Paul A.
    Mooberry, Susan L.
    [J]. MOLECULAR PHARMACEUTICS, 2006, 3 (04) : 457 - 467
  • [8] SITE OF ACTION OF 2 NOVEL PYRIMIDINE BIOSYNTHESIS INHIBITORS ACCURATELY PREDICTED BY THE COMPARE PROGRAM
    CLEAVELAND, ES
    MONKS, A
    VAIGROWOLFF, A
    ZAHAREVITZ, DW
    PAULL, K
    ARDALAN, K
    COONEY, DA
    FORD, H
    [J]. BIOCHEMICAL PHARMACOLOGY, 1995, 49 (07) : 947 - 954
  • [9] Simple, intuitive calculations of free energy of binding for protein-ligand complexes. 1. Models without explicit constrained water
    Cozzini, P
    Fornabaio, M
    Marabotti, A
    Abraham, DJ
    Kellogg, GE
    Mozzarelli, A
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (12) : 2469 - 2483
  • [10] Intrinsic chemotherapy resistance to the tubulin-binding antimitotic agents in renal cell carcinoma
    Ferguson, RE
    Jackson, SM
    Stanley, AJ
    Joyce, AD
    Harnden, P
    Morrison, EE
    Patel, PM
    Phillips, RM
    Selby, PJ
    Banks, RE
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2005, 115 (01) : 155 - 163